219 related articles for article (PubMed ID: 29455115)
1. Therapeutic use of heparin and derivatives beyond anticoagulation in patients with bronchial asthma or COPD.
Shute JK; Puxeddu E; Calzetta L
Curr Opin Pharmacol; 2018 Jun; 40():39-45. PubMed ID: 29455115
[TBL] [Abstract][Full Text] [Related]
2. Statins in the treatment of COPD and asthma-where do we stand?
So JY; Dhungana S; Beros JJ; Criner GJ
Curr Opin Pharmacol; 2018 Jun; 40():26-33. PubMed ID: 29334676
[TBL] [Abstract][Full Text] [Related]
3. Pleiotropic effects of hypoglycemic agents: implications in asthma and COPD.
Rogliani P; Ora J; Di Daniele N; Lauro D
Curr Opin Pharmacol; 2018 Jun; 40():34-38. PubMed ID: 29427967
[TBL] [Abstract][Full Text] [Related]
4. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of inhaled corticosteroids in chronic obstructive pulmonary disease: similarities and differences to asthma.
Jeffery P
Expert Opin Investig Drugs; 2005 May; 14(5):619-32. PubMed ID: 15926868
[TBL] [Abstract][Full Text] [Related]
6. Pepducins as a potential treatment strategy for asthma and COPD.
Panettieri RA; Pera T; Liggett SB; Benovic JL; Penn RB
Curr Opin Pharmacol; 2018 Jun; 40():120-125. PubMed ID: 29729548
[TBL] [Abstract][Full Text] [Related]
7. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
Zervas E; Samitas K; Gaga M
Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
[TBL] [Abstract][Full Text] [Related]
8. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
[TBL] [Abstract][Full Text] [Related]
9. Patient preferences in severe COPD and asthma: a comprehensive literature review.
Bereza BG; Troelsgaard Nielsen A; Valgardsson S; Hemels ME; Einarson TR
Int J Chron Obstruct Pulmon Dis; 2015; 10():739-44. PubMed ID: 25914530
[TBL] [Abstract][Full Text] [Related]
10. Targeting arginase and nitric oxide metabolism in chronic airway diseases and their co-morbidities.
van den Berg MP; Meurs H; Gosens R
Curr Opin Pharmacol; 2018 Jun; 40():126-133. PubMed ID: 29729549
[TBL] [Abstract][Full Text] [Related]
11. Nebulized Heparin Attenuates Pulmonary Coagulopathy and Inflammation through Alveolar Macrophages in a Rat Model of Acute Lung Injury.
Chimenti L; Camprubí-Rimblas M; Guillamat-Prats R; Gomez MN; Tijero J; Blanch L; Artigas A
Thromb Haemost; 2017 Nov; 117(11):2125-2134. PubMed ID: 29202212
[No Abstract] [Full Text] [Related]
12. Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets.
Rahman I
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):291-315. PubMed ID: 14561194
[TBL] [Abstract][Full Text] [Related]
13. Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome.
Suzuki T; Tada Y; Kawata N; Matsuura Y; Ikari J; Kasahara Y; Tatsumi K
Int J Chron Obstruct Pulmon Dis; 2015; 10():947-54. PubMed ID: 26028967
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Tolerability of an Inhaled Selective Glucocorticoid Receptor Modulator - AZD5423 - in Chronic Obstructive Pulmonary Disease Patients: Phase II Study Results.
Kuna P; Aurivillius M; Jorup C; Prothon S; Taib Z; Edsbäcker S
Basic Clin Pharmacol Toxicol; 2017 Oct; 121(4):279-289. PubMed ID: 28212463
[TBL] [Abstract][Full Text] [Related]
15. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.
Tse HN; Tseng CZ
Int J Chron Obstruct Pulmon Dis; 2014; 9():825-36. PubMed ID: 25125976
[TBL] [Abstract][Full Text] [Related]
16. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.
Donohue JF; Ohar JA
Proc Am Thorac Soc; 2004; 1(3):152-60. PubMed ID: 16113428
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for asthma.
Walsh GM
Expert Opin Emerg Drugs; 2008 Dec; 13(4):643-53. PubMed ID: 19046132
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy.
Kirkham P; Rahman I
Pharmacol Ther; 2006 Aug; 111(2):476-94. PubMed ID: 16458359
[TBL] [Abstract][Full Text] [Related]
19. Use of inhaled corticosteroids in COPD: improving efficacy.
Yang IA; Shaw JG; Goddard JR; Clarke MS; Reid DW
Expert Rev Respir Med; 2016; 10(3):339-50. PubMed ID: 26855301
[TBL] [Abstract][Full Text] [Related]
20. The challenge of diagnosing a mixed asthma-COPD phenotype (ACOS) in clinical practice.
García-García Mdel C; Hernández-Borge J; Barrecheguren M; Miravitlles M
Ther Adv Respir Dis; 2016 Apr; 10(2):175-8. PubMed ID: 26968234
[No Abstract] [Full Text] [Related]
[Next] [New Search]
